Cramer Manhem Monica
Known title: Pres., Int'l ReinsuranceCIK: 0001758144
Associated companies
Transaction History
| SPNT | ▼ Sell | Tax Withholding | 74,993 | $0 | 12/31/2022 | View on chart |
| SPNT | ▼ Sell | Tax Withholding | 4,351 | $28K | 4/14/2022 | View on chart |
| SPNT | ▲ Buy | Grant | 91,650 | $0 | 4/6/2022 | View on chart |
| SPNT | ▲ Buy | Grant | 7,556 | $0 | 4/6/2022 | View on chart |
| SPNT | ▼ Sell | Tax Withholding | 66,333 | $494K | 2/27/2022 | View on chart |
| SPNT | ▼ Sell | Tax Withholding | 46,153 | $375K | 12/31/2021 | View on chart |
| SPNT | ▲ Buy | Grant | 0 | $0 | 12/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
SiriusPoint (SPNT) Valuation Questioned After Recent Price Rise
Recent market discussion has focused on whether SiriusPoint remains undervalued following a recent increase in its share price. The company currently trades with a low trailing P/E ratio of 5.7, which is significantly below the average analyst target of $28.75. This valuation gap has prompted investors to reassess the stock's position within its 52-week range of $17.39 to $26.50.
SiriusPoint (SPNT) Valuation Questioned After Recent Price Rise. Recent market discussion has focused on whether SiriusPoint remains undervalued following a recent increase in its share price. The company currently trades with a low trailing P/E ratio of 5.7, which is significantly below the average analyst target of $28.75. This valuation gap has prompted investors to reassess the stock's position within its 52-week range of $17.39 to $26.50.